Suspension of trading
Quotes Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 24-10-01 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 24-09-30 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Performance
| 3 years | -63.75% | ||
| 5 years | -96.59% | ||
| 10 years | -98.52% |
Volumes
marketsDaily volume
1,592
Estimated daily volume
1,592
Record volume 1
2,936,479
Record volume 2
1,307,405
Record volume 3
975,732
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
12,586,774
Net sales ()
16
Number of employees
25
Sales / Employee ()
1
Sales / Employee (USD)
1
Free-Float
86.47 %
Free-Float capitalization (USD)
10,883,196
Indicators
Moving average 5 days
8.5
Moving average 100 days
8.438
Price spread / (MMA5)
-.--%
Price spread / (MMA100)
-0.72%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -63.75% | 12.59M | |
| -5.20% | -7.33% | -2.92% | +10.98% | 48.5B | |
| +1.61% | -0.91% | +377.07% | +584.68% | 38.97B | |
| +2.61% | +3.96% | +9.16% | +61.36% | 35.43B | |
| -1.12% | -2.99% | +26.84% | -11.67% | 33.65B | |
| -0.58% | -0.69% | -0.56% | +30.30% | 26.58B | |
| +1.37% | -3.90% | - | - | 16.82B | |
| +0.71% | -0.84% | +72.13% | +116.76% | 15.18B | |
| -0.69% | -0.14% | +9.22% | +13.07% | 13.89B | |
| +0.26% | -0.80% | +19.33% | -32.25% | 12.76B | |
| Average | -0.10% | -0.84% | +56.70% | +78.83% | 24.18B | |
| Weighted average by Cap. | -0.51% | -1.00% | +76.61% | +121.99% |
Historical Quotes: Eiger BioPharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 1.1 |  | 28.5 |
| 5 years | 1.1 | | 300.64 |
| 10 years | 1.1 | | 618.9 |
Monthly variations
Annual variations
| 2024 | +26.21% | ||
| 2023 | -80.97% | ||
| 2022 | -77.26% | ||
| 2021 | -57.77% | ||
| 2020 | -17.52% | ||
| 2019 | +46.65% | ||
| 2018 | -27.17% | ||
| 2017 | +19.74% | ||
| 2016 | -26.69% |
- Stock Market
- Stocks
- EIGR Stock
- Quotes Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
